Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
- Citation:
- J Clin Oncol vol 25 (24) 3699-704
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Comprehensive
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA32291, CA33601, CA35279, CA60138, CA77406, CA77651, CAII028
- Corr. Author:
- Authors:
- Hyman B Muss Donald A Berry Constance Cirrincione Daniel R Budman I Craig Henderson Marc L Citron Larry Norton Eric P Winer Clifford A Hudis
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-8541, CALGB-9741
- Phases:
- 3
- Keywords:
- Age Factors, Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Chemotherapy, Adjuvant, Cyclophosphamide, Doxorubicin, Female, Humans, Leukemia, Myeloid, Acute, Lymphatic Metastasis, Middle Aged, Myelodysplastic Syndromes, Neoplasms, Second Primary, Paclitaxel